Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NIA Aleve Vs. Vioxx Alzheimer's Study To Produce Data By 2002

This article was originally published in The Tan Sheet

Executive Summary

A National Institute on Aging study comparing Bayer's OTC Aleve and Merck's Rx Vioxx in Alzheimer's patients will produce data in two and a half years.

You may also be interested in...



NSAID Alzheimer’s Risk-Reduction Effects May Vary By Age – Study

The apparent effect of non-steroidal anti-inflammatory drugs in reducing the risk of Alzheimer's disease may depend, in part, on a subject's age, Johns Hopkins University researchers suggest in the Sept. 24 issue of Neurology

NSAID Alzheimer’s Risk-Reduction Effects May Vary By Age – Study

The apparent effect of non-steroidal anti-inflammatory drugs in reducing the risk of Alzheimer's disease may depend, in part, on a subject's age, Johns Hopkins University researchers suggest in the Sept. 24 issue of Neurology

NSAID Alzheimer’s Risk-Reduction Effects May Vary By Age – Study

The apparent effect of non-steroidal anti-inflammatory drugs in reducing the risk of Alzheimer's disease may depend, in part, on a subject's age, Johns Hopkins University researchers suggest in the Sept. 24 issue of Neurology

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090888

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel